Cocrystal Pharma Inc
COCP
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.48M
Close$
$0.49
53.9% downside
Current Fair Value
53.9% downsideOvervalued by 53.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.48 Million |
|---|---|
| Enterprise Value | $8.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 1.5 |
| Outstanding Shares | 13,786,000 |
Return
| Return on Equity | -214.50% |
|---|---|
| Return on Assets | -118.89% |
| Return on Invested Capital | -174.85% |
Valuation & Multiples
| P/E Ratio | -1.75 |
|---|---|
| PEG | 2012.02 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.9 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$225,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.88%▼ 0.14% |
|---|---|
| Total Invested | $783,754▲ 3.90% |
| Investors Holding | 25▼ 1.00% |
ESG Score
No data
About Cocrystal Pharma Inc
CEO: Gary Wilcox